 | This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Roger Corder
Roger Corder (born 29th November 1955) is a Professor of Experimental Therapeutics at the William Harvey Research Institute at Barts and The London School of Medicine and Dentistry, the medical school of the Queen Mary, University of London and author of the book The Wine Diet.
Roger grew up in southwest England on a dairy farm on the edge of the Blackdown Hills - an Area of Outstanding Natural Beauty. He was a pupil at Wellington School in Somerset - alma mater of actor David Suchet, chef and TV personality Keith Floyd, and author Jeffrey Archer. After leaving school, Roger read for a BSc in pharmacy at the School of Pharmacy in Portsmouth. Following this he took a pre-registration position in North East Thames Regional Heath Authority, which included training in clinical pharmacy at St. Bartholomew’s Hospital.
After qualifying as a pharmacist in 1978 and registering as a Member of the Royal Pharmaceutical Society of Great Britain, the opportunity arose for Roger to take up a career in medical research through positions in Endocrinology and Chemical Pathology at the Medical College of St. Bartholomew’s Hospital. He obtained an MSc in Pharmacology from the University of East London in 1981, and was later awarded a PhD in 1986 from the University of London for his studies of Neuropeptide Y.
After seven years doing research at Barts, for which he was awarded his PhD, Roger moved to Switzerland where he undertook research for five years in the Department of Medicine at the University of Geneva. In 1991, Roger returned to London to work with Nobel Laureate Sir John Vane and assume the position of senior scientist leading endothelin research at the William Harvey Research Institute.
He became Professor of Experimental Therapeutics in 2000. Since 2000 he has also been chairman of the management committee of the William Harvey Research Foundation. Roger is a professional member of the American Heart Association, and the American Society for Pharmacology and Experimental Therapeutics. In the UK he is a Fellow of the Royal Society of Medicine, and a member of the Society for Endocrinology, and the British Pharmacological Society.